Skip to content

Merck buys protease inhibitor from Ambrilia, may be potent booster of other PIs

Reduced dose of Kaletra soft-gel capsule effective in small study (corrected)

Darunavir: negative interactions with Kaletra, Viagra and contraceptive pill reported

Kaletra dose may need to rise in late pregnancy

Rifampicin levels strongly reduced in patients with TB and diabetes

Genetic marker predicts liver harm from nevirapine or efavirenz

Ranbaxy presents bioequivalence data on two paediatric fixed dose triple combination tablets

Acid-reducing agent increases saquinavir levels in HIV-negative volunteers

Conflicting pharmacokinetic results when lopinavir and atazanavir are double-boosted with ritonavir